Breast Biopsy Market – Overview
Increased
cancer detection rates globally have contributed to a rise in biopsy
procedures. Market reports connected with the healthcare industry have
been presented by Market Research Future which makes reports on other
industry verticals that aims to analyze the current market scenarios
better. The market is projected to develop at a favorable CAGR rate in
the forecast 2018-2023.
Free Sample Copy of With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288
The
prevalence of breast cancer has led to an increased level of reliance
on breast biopsy procedures. Improved screening campaigns are also
increasing the need for breast biopsy procedures. Furthermore, the rise
in the awareness regarding cancer is anticipated to further motivate the
expansion of the breast biopsy market in the forecast period.
Competitive Analysis:
Leading players in the global Biopsy Breast Market Procedure
include Sonocine Inc., Toshiba Corporation, Gamma Medica Inc., Aurora
Imaging Technology Inc., Dilon Technologies Inc., Fujifilm Holdings
Corporation, Hologic Inc., Koninklijke Philips N.V., Siemens, and GE.
In
September 2019, Candelis Inc. launched a new Advanced Breast Imaging
Workstation as an enhancement to its ImageGrid platform.
Segmentation:
The
breast cancer market has been segmented on the basis of product,
technique type, guidance technology, and end-user. On the basis of
product, the market has been classified as biopsy needles, biopsy
tables, biopsy wires, and guidance systems. On the basis of technique
type, the market is classified into fine needle aspiration biopsy, core
needle biopsy, biopsy markers, MRI-guided core needle biopsy, incisional
biopsy, excisional biopsy, wire localization, and sentinel node biopsy.
Further, the core needle biopsy subsegment is segmented into
stereotactic core needle biopsy, vacuum-assisted biopsy,
ultrasound-guided core biopsy, and freehand core-needle biopsy. The
surgical biopsy sub-segment is segmented into incisional biopsy and
excisional biopsy. On the basis of guidance technology, the market is
classified into ultrasound-guided, mammography-guided magnetic
resonance, CT-guided biopsy, and other image-guided breast biopsy (PET
and thermography). On the basis of end-user, the market is divided into
hospitals, ambulatory surgical centers, diagnostic centers, and others
Regional Analysis:
The
Americas is the largest regional market for breast imaging. The
widespread awareness about breast cancer in the region has been a
primary driver for the breast imaging market, as it has driven
consistent product development in the breast imaging market. Women in
the country don’t view breast cancer as a taboo and are proactive in
fighting the disease on their own terms. This has driven significant
growth of the breast imaging market. The growing prevalence of breast
cancer in the region is also likely to remain a major driver for the
breast imaging market in the Americas.
Europe
holds the second largest share in the global breast imaging market,
followed by Asia Pacific. China, Japan, and India are likely to emerge
as important markets in the coming years, enabling steady growth of the
breast imaging market in Asia Pacific.
Key players
Some
of the key players in the global breast biopsy market are Leica
Biosystems, C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices,
Inc., Becton, Dickinson and Company, Devicor Medical Products Inc.
Hologic Inc. Argon Medical Devices, Cook Medical Incorporated, Encapsule
Medical Devices LLC., Johnson & Johnson, Galini SRL, Intact Medical
Corporation, Conceptus INC, Hologic Inc., Karl Storz GmbH & Co. Kg,
and GE Healthcare.
LIST OF TABLES
Table 1 Breast Biopsy Market Industry Synopsis, 2018–2023
Table 2 Global Breast Biopsy Market Estimates & Forecast, 2018–2023, (USD Million)
Table 3 Global Breast Biopsy Market, by Region, 2018–2023, (USD Million)
Table 4 Global Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)
Table 5 Global Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)
Table 6 Global Breast Biopsy Market, by End-User, 2018–2023, (USD Million)
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288
Browse Related Reports
Tracheostomy Products Market
Gastroparesis Treatment Market
Healthcare Asset Management Market
About Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR
team have supreme objective to provide the optimum quality market
research and intelligence services to our clients. Our market research
studies by Components, Application, Logistics and market players for
global, regional, and country level market segments, enable our clients
to see more, know more, and do more, which help to answer all their most
important questions.
In
order to stay updated with technology and work process of the industry,
MRFR often plans conducts meet with the industry experts and industrial
visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
https://marketreports4u.blogspot.com/
Comments
Post a Comment